rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Pulmatrix, Inc.

PULM · Nasdaq

Health CareBiotechnologyNot moving yet

PULM stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 9.9% below that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
15% -17 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
14 (+0)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

17 Apr – 16 Oct
16%28%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$1$0$1Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders14+0 on the quarter
New · exited2 · 2
Reported value$569K

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
RENAISSANCE TECHNOLOGIES LLCadded · filed 13 Aug 2026122,698$209K+13,550+12.4%
BlackRock, Inc.unchanged · filed 7 Aug 202654,899$93K00.0%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 202633,299$57K-11,330−25.4%
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 202632,294$55K-1,300−3.9%
SBI Securities Co., Ltd.added · filed 23 Jul 202631,285$53K+1,200+4.0%
Shay Capital LLCnew · filed 14 Aug 202618,857$32K+18,857
VANGUARD FIDUCIARY TRUST COunchanged · filed 13 Aug 202614,715$25K00.0%
STATE STREET CORPunchanged · filed 7 Aug 202613,945$24K00.0%
XTX Topco Ltdreduced · filed 14 Aug 202611,991$20K-1,678−12.3%
UBS Group AGadded · filed 13 Aug 2026515$875+492+2139.1%
31 Mar 2023 – 30 Jun 2026
101214Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Anand Varadan Company insiderDirector · last 26 Jan 20230 · 0
Christopher Cabell Company insiderDirector · last 26 Jan 20230 · 0
Margaret Wasilewski Company insiderChief Medical Officer · last 26 Jan 20230 · 0
Michael J. Higgins Company insiderDirector · last 26 Jan 20230 · 0
Michelle Siegert Company insiderVice President, Finance · last 26 Jan 20230 · 0
Richard P. Batycky Company insiderDirector · last 26 Jan 20230 · 0
Teofilo David Raad Company insiderChief Executive Officer · last 26 Jan 20230 · 0
Todd Bazemore Company insiderDirector · last 26 Jan 20230 · 0
Amit Munshi Company insiderDirector · last 28 Jan 20210 · 0
Mark T. Iwicki Company insiderDirector · last 28 Jan 20211 · 0
Steven Gillis Company insiderDirector · last 28 Aug 20200 · 0
Matthew L. Sherman Company insiderDirector · last 16 May 20191 · 0

Same industry

MRNA ModernaLeading+147%
IOVA Iovance BiotherapeuticsLeading+126%
ABCL AbCellera BiologicsLeading+60%
HALO Halozyme TherapeuticsLeading+46%
XERS Xeris Biopharma HoldingsLeading+38%
ENTX Entera BioLeading+37%
HELP Helus PharmaLeading+36%
XNCR XencorLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-136%
Share count trendFY 2025 · to 23 Feb 20260.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$4.1M

Analyst forecasts

No analyst forecasts yet.